Authors: Li, Xin-Yi | Chen, Ming-Jia | Liang, Xiao-Niu | Yao, Rui-Xin | Shen, Bo | Wu, Bin | Li, Gen | Sun, Yi-Min | Wu, Jian-Jun | Liu, Feng-Tao | Yang, Yu-Jie | Wang, Jian
Background: The self-reported quality of life (QoL) should be carefully listened to in progressive supranuclear palsy (PSP) from the patient-centered perspective. However, there was still a lack of short QoL measurement tool in atypical parkinsonism. Objective: We aimed to test whether the short Parkinson’s Disease Questionnaire-8 (PDQ-8) was effective in assessing QoL in PSP, comparing with Progressive Supranuclear Palsy Quality of Life Scale (PSP-QoL) and Parkinson’s Disease Questionnaire-39 (PDQ-39). Methods: 132 patients with clinical diagnosed PSP, including PSP-Richardson syndrome (RS) subtype (n = 71) and PSP-non-RS subtype (n = 61) were recruited for clinical
…evaluation including QoL assessment. The detailed QoL profiles and possibility of using PDQ-8 were systemically analyzed. The determinants to the QoL were then calculated by multivariate linear regression analysis. Results: The PSP-QoL total score summary index (SI) was 22.8 (10.1, 41.1), while the PDQ-8 and PDQ-39 total SI score were 28.1 (12.5, 46.9) and 29.5 (15.4, 49.4). Mobility, activities of daily life, cognition and communication were the main affected QoL subdomains (median SI: 40.0, 31.3, 25.0 and 25.0 respectively). PSP-RS subtype showed more severe damage physically (p <0.001) and mentally (p = 0.002) compared to other subtypes. More importantly, the strong relevance of PDQ-8 and recommended PSP QoL tools were confirmed (p <0.001). In addition, disease severity, depression and daytime sleepiness were proved to be critical determinants for QoL in PSP. Conclusions: PDQ-8 could be an easy, reliable, and valid tool to evaluate QoL in patients with PSP. Besides motor symptoms, more attention should be paid to non-motor impairment such as depression in PSP.
Keywords: Health-related quality of life, PDQ-8, PSP-QoL, progressive supranuclear palsy
Citation: Journal of Parkinson's Disease,
vol. 13, no. 1, pp. 83-91, 2023